Skip to main content
Clinical Trials/NCT06548581
NCT06548581
Active, not recruiting
Not Applicable

Radiographic and Patient Reported Outcomes Following Joint Arthrodesis Following the Use of the SpeedPlate™ Rapid Compression Implants: An Ambidirectional Cohort Study

Treace Medical Concepts, Inc.5 sites in 1 country92 target enrollmentSeptember 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Joint Arthrodesis
Sponsor
Treace Medical Concepts, Inc.
Enrollment
92
Locations
5
Primary Endpoint
Evaluate union vs non-union
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

Post-market, observational, multicenter, unblinded, ambidirectional cohort study to evaluate outcomes of study participants treated with the SpeedPlate™ product.

Up to 200 participants will be treated in this study at (up to) 15 clinical sites.

Patients 14 years of age or older that have had MTP and/or TMT joint fixation with the SpeedPlate™ Rapid Compression Implants will be eligible to participate based on the inclusion and exclusion criteria defined in this protocol.

Detailed Description

The objectives of this study are to evaluate: 1. Healing/union rates following joint fixation using the SpeedPlate™ Rapid Compression Implants 2. Whether early weight-bearing (WB) following joint fixation using the SpeedPlate™ Rapid Compression Implants affects the healing/union rates 3. Quality of life, pain scores and patient satisfaction following joint arthrodesis using the SpeedPlate™ Rapid Compression Implants

Registry
clinicaltrials.gov
Start Date
September 4, 2024
End Date
December 2026
Last Updated
10 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients satisfying the following criteria will be considered and eligible for participation:
  • Patients who have had MTP and/or TMT joint fixation using at least one SpeedPlate™ Rapid Compression Implant (Index Procedure);
  • Males and females ages 14 years of age or older at the time of the Index Procedure;
  • Patients who have completed at least their 6-week post-operative visit but have not yet completed their 12-month post-operative visit;
  • Adequate pre-operative AP and lateral weight-bearing radiographs collected within 6 months of the Index Procedure;
  • Patients must be capable of completing self-administered questionnaires;
  • Willing and able to provide written informed consent.

Exclusion Criteria

  • Patients satisfying the following criteria will not be eligible for participation:
  • Female patients of childbearing potential with positive pregnancy result at time of consent;
  • Unwilling or unable to schedule and return for follow-up visits;
  • Surgery for MTP or TMT joint arthrodesis on operative foot prior to Index Procedure;
  • Joint arthrodesis using other plating constructs in addition to the SpeedPlate™ Implant(s) at MTP or TMT joint at the time of Index Procedure;
  • Surgeries on operative foot involving fusion of the foot or ankle joints prior to, or at the time of, Index Procedure (other than hammertoe or lesser toes/digits);
  • Clinically significant neuropathy at time of Index Procedure;
  • Untreated Moderate - Severe Osteoarthritis of 1st, 2nd, or 3rd TMT or MTP during the Index Procedure;
  • Untreated Moderate - Severe Osteoarthritis of the foot or ankle outside of the 1st, 2nd or 3rd TMT or MTP joints at the time of Index Procedure;
  • BMI \>40 kg/m² at time of Index Procedure;

Outcomes

Primary Outcomes

Evaluate union vs non-union

Time Frame: 12 Months

Evaluate clinical/radiographic healing (union vs non-unio). Non-union is defined as radiographic lucency and clinical pain at the 1st, 2nd, and/or 3rd TMT or MTP joint at 12 months post Index.

Secondary Outcomes

  • Evaluate non-surgical clinical complications or health conditions that could affect outcomes related to the implants or procedure.(24 Months)
  • Evaluate the Intermetatarsal Angle(6 Weeks, 3-4 Months, 6 Months, 12 Months, 24 Months)
  • Evaluate time to start weight-bearing in shoes.(Days after surgery - on average up to 6 weeks)
  • Evaluate patient-reported quality of life, post surgery.(6 Months, 12 Months, 24 Months)
  • Evaluate patient-reported satisfaction, post surgery.(12 Months, 24 Months)
  • Evaluate surgical clinical complications or health conditions that could affect outcomes related to the implants or procedure.(24 Months)
  • Evaluate the Tibial Sesamoid(6 Weeks, 3-4 Months, 6 Months, 12 Months, 24 Months)
  • Evaluate time to start weight-bearing in a boot.(Days after surgery - on average up to 2 weeks)
  • Evaluate time to start unrestricted activity.(Days after surgery - on average up to 4 months)
  • Evaluate the Hallux Valgus Angle(6 Weeks, 3-4 Months, 6 Months, 12 Months, 24 Months)
  • Evaluate patient-reported pain, post surgery.(6 Months, 12 Months, 24 Months)

Study Sites (5)

Loading locations...

Similar Trials